| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 37,594 | 37,651 | 39,105 | 43,656 | | Cost of Revenue | 24,311 | 25,887 | 26,826 | 32,379 | | | Gross Profit | 13,283 | 11,764 | 12,279 | 11,277 | | | Operating Expenses | | Research Development | 1,755 | 2,309 | 2,069 | 1,976 | | Selling General and Administrative | 7,222 | 7,120 | 8,339 | 8,386 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,306 | 2,335 | 1,871 | 915 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 305 | (139) | 486 | (344) | | Earnings Before Interest And Taxes | 4,611 | 2,196 | 2,357 | 571 | | Interest Expense | 1,422 | 1,517 | 1,597 | 1,596 | | Income Before Tax | 3,189 | 679 | 760 | (1,025) | | Income Tax Expense | 562 | 238 | 266 | (359) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,627 | 441 | 494 | (666) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,627 | 441 | 494 | (666) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,627 | $441 | $494 | ($666) |
|
0.31% Nasdaq 
0.05%
Income Statement
